PROPANC BIOPHARMA, INC. (PPCB) Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

PROPANC BIOPHARMA, INC. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

PROPANC BIOPHARMA, INC. (PPCB) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $1.14 million for the 12-month period ending 2020-06-30, per its 10-K filed 2020-10-01.

Discontinued › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2020-10-01

• PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2020 was $1.14M, a 18.41% decline from fiscal 2019.
• PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2019 was $1.39M, a 1.69% decline from fiscal 2018.
• PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2018 was $1.42M, a 60.88% increase from fiscal 2017.
• PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2017 was $881.60K, a 2.13% decline from fiscal 2016.